Parallel Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29K | Sell |
2,506
-15,082
| -86% | -$175K | ﹤0.01% | 2000 |
|
|
2025
Q1 | $154K | Buy |
17,588
+2,686
| +18% | +$23.4K | ﹤0.01% | 1065 |
|
|
2024
Q4 | $214K | Sell |
14,902
-2,321
| -13% | -$33.3K | ﹤0.01% | 900 |
|
|
2024
Q3 | $389K | Buy |
17,223
+1,118
| +7% | +$25.2K | 0.01% | 662 |
|
|
2024
Q2 | $313K | Sell |
16,105
-489
| -3% | -$9.51K | 0.01% | 700 |
|
|
2024
Q1 | $623K | Sell |
16,594
-7
| -0% | -$263 | 0.02% | 468 |
|
|
2023
Q4 | $929K | Sell |
16,601
-773
| -4% | -$43.3K | 0.03% | 350 |
|
|
2023
Q3 | $717K | Buy |
17,374
+4
| +0% | +$165 | 0.02% | 374 |
|
|
2023
Q2 | $970K | Sell |
17,370
-9
| -0.1% | -$503 | 0.03% | 318 |
|
|
2023
Q1 | $970K | Sell |
17,379
-3,010
| -15% | -$168K | 0.03% | 316 |
|
|
2022
Q4 | $743K | Buy |
20,389
+154
| +0.8% | +$5.61K | 0.03% | 314 |
|
|
2022
Q3 | $576K | Buy |
20,235
+69
| +0.3% | +$1.96K | 0.03% | 358 |
|
|
2022
Q2 | $913K | Sell |
20,166
-68
| -0.3% | -$3.08K | 0.04% | 259 |
|
|
2022
Q1 | $1.51M | Buy |
20,234
+12,810
| +173% | +$957K | 0.06% | 206 |
|
|
2021
Q4 | $1.11M | Buy |
7,424
+7,414
| +74,140% | +$1.1M | 0.04% | 255 |
|
|
2021
Q3 | $1K | Sell |
10
-1
| -9% | -$100 | ﹤0.01% | 2948 |
|
|
2021
Q2 | $2K | Sell |
11
-3,469
| -100% | -$631K | ﹤0.01% | 2600 |
|
|
2021
Q1 | $630K | Buy |
3,480
+3,462
| +19,233% | +$627K | 0.03% | 310 |
|
|
2020
Q4 | $3K | Buy |
+18
| New | +$3K | ﹤0.01% | 2208 |
|